Products
Sherpa
Drafter
Researcher
Reviewer
Audiences
MedTech
Startups
Consultants
Guideways.ai
About us
Technology
FAQ
Trust
News & Insights
Contact us
Why MedTech VCs should focus on Regulatory Predictability to Unlock Returns
In my recent open letter to founders, “The MedTech Valley of Death”[8], I made a blunt assertion. Eliminating unforced regulatory errors to secure a 30 percent faster FDA clearance is the ultimate survival lever for an early-stage MedTech CEO. But...
Navigating the Medtech Maze: Insights from 5 Founders on Regulatory Momentum
By Alexander Habermeier What does building ambitious health technology look like when regulatory approval is part of the equation from day one? On February 12th, during the Guideways Launch Event in Utrecht, we gathered a group of innovators who are moving the needle...